Le Lézard
Classified in: Health, Covid-19 virus
Subjects: NPT, WOM, TRI, FVT, DEI

NATIONAL CANCER PREVENTION WORKSHOP RETURNS VIRTUALLY STARTING FEB. 2


RYE, N.H., Jan. 18, 2022 /PRNewswire/ -- The February 2-4, 2022 National Cancer Prevention Workshop is designed to educate students and legislators while providing continuing education credits for physicians, nurses, and public health professionals. The 2022 event is being held virtually and will be live-streamed on demand on Coursera and air live on Less Cancer's social media channels.

Less Cancer and its partners hope to return the event to Capitol Hill in Washington, DC in 2023 when the COVID-19 virus subsides.

"Our bipartisan focus is on cancer prevention," said Less Cancer founder Bill Couzens. "We have one of our most dynamic lineups ever with nearly 70 presenters focusing on prevention, public health, risk-reduction strategies, healthy lifestyle choices, and much more."

Sure to be one of the event's most provocative conversations will be the workshop on the relationship between alcohol use and breast cancer.  The workshop features Priscilla Martinez, Ph.D., a scientist with the Alcohol Research Group at the Public Health Institute.  The session focuses on the evidence linking alcohol use to breast cancer risk and the lack of awareness of this link. It also highlights the Drink Less for Your Breasts campaign that aimed to raise awareness among young women that alcohol use is a breast cancer risk factor.  

Research shows alcohol consumption increases the risk of breast cancer by up to 16 percent. Yet, a 2019 study published in the journal, Preventive Medicine, reports that only 25 percent of women ages 15 to 44 were aware of this connection.

"The Less Cancer National Cancer Prevention Workshop is a highly impactful venue where we can call attention to the research demonstrating the clear relationship between alcohol consumption and breast cancer," said Dr. Martinez.  "By bringing together all the key stakeholders from academia, government, and medicine, Less Cancer's unique focus on prevention can have a meaningful effect on reducing the incidence of cancer."

Continuing education credits are provided for healthcare and public health professionals by the University of Virginia School of Medicine and School of Nursing, and American University.

After Feb. 4, the workshop will be available on YouTube and Coursera. 

National Cancer Prevention Day first came about through a House of Representatives resolution led by Less Cancer on February 4, 2013. It states that work to prevent cancer impacts human health, the environment, and the economy. 

For more information, visit www.lesscancer.org

About Less Cancer
Founded in 2004, the Next Generation Choices Foundation is a 501(c)(3) public charity known more widely as "Less Cancer." The organization works to educate the public, create proactive public policies, and offer continuing education credit to physicians, nurses, and public health professionals regarding cancer, over 50 percent of which are preventable. Less Cancer signifies a new paradigm for addressing cancer, focused on prevention. This is a departure from previous treatment-focused approaches, which focus on beating, conquering, or curing cancer.

MEDIA CONTACT: Colleen Robar, 313-207-5960, [email protected]

SOURCE Less Cancer


These press releases may also interest you

at 08:07
Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life science pioneers, has released a comprehensive contract research organization (CRO) offering tailor-made for sponsors looking to bring diagnostic products...

at 08:05
Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today the enrollment of the first patient in a pilot study collecting patient-generated health data (PGHD) during proton radiotherapy for lung cancer in...

at 08:05
Roivant and Kinevant Sciences, a clinical-stage biopharmaceutical company developing new medicines for rare inflammatory and autoimmune diseases, today announced the successful completion of enrollment in its Phase 2 study evaluating namilumab for...

at 08:05
Revvity, Inc. will present at the BofA Securities 2024 Health Care Conference on Tuesday, May 14, 2024 at 8:40 a.m. PT in Las Vegas, NV. Senior Vice President and Chief Financial Officer Max Krakowiak will provide an update on the Company and its...

at 08:05
Freedom Biosciences, Inc. ("Freedom Bio" or the "Company"), a clinical-stage biotechnology platform focused on developing next-generation neuropsychiatric therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has notified the...

at 08:05
Microbion Corporation today announced that the company won the Advanced Wound Care Summit's Innovation Showcase award. The Innovation Showcase was designed to give presenters, who were picked by a selection committee, an opportunity to demonstrate...



News published on and distributed by: